One Stop Shop for All Your Market Research Reports

Global Oncology/Cancer Drugs Market 2018 Industry Research Report

This report studies the global market size of Oncology/Cancer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oncology/Cancer Drugs in these regions. This research report categorizes the global Oncology/Cancer Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. Medical oncologists specialise in cancer treatment using drugs such as chemotherapy agents. USFDA and European Union have undertaken significant initiatives to fuel the growth of global oncology/cancer drugs market by providing pre-market approval for potential drugs under clinical development. Asia-Pacific and LAMEA are promising regions for conducting clinical trials due a large population base and the low cost of clinical trials as compared to North America and Europe Japan has largest share to the total Asia Pacific cancer drug market due to the high prevalence of cancer in Japanese population. Lung cancer is the major cause of death in Japanese population. In 2017, the global Oncology/Cancer Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Oncology/Cancer Drugs market based on company, product type, application and key regions. The various contributors involved in the value chain of Oncology/Cancer Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Oncology/Cancer Drugs include Amgen Johnson & Johnson GlaxoSmithKline Eli lilly Roche diagnostics Novartis Pfizer Merck Sanofi Celgene Roche Novartis Celgene Market Size Split by Type Blood Cancer Breast Cancer Gastrointestinal Cancer Prostate Cancer Respiratory/Lung Cancer Skin Cancer Other Cancers Market Size Split by Application Hospital Clinic Pharmacy Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Oncology/Cancer Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Oncology/Cancer Drugs market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Oncology/Cancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Oncology/Cancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Oncology/Cancer Drugs submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Oncology/Cancer Drugs are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oncology/Cancer Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Oncology/Cancer Drugs Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Type 1.4.2 Blood Cancer 1.4.3 Breast Cancer 1.4.4 Gastrointestinal Cancer 1.4.5 Prostate Cancer 1.4.6 Respiratory/Lung
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Corporate User US $7800
About this Report
Report ID 277860
Category
  • Pharmaceuticals and Healthcare
Published on 22-Aug
Number of Pages 97
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(36)